NeuroLucent is an early-stage company focused on developing small-molecule therapeutics to treat the cognitive loss associated with Alzheimer's disease. We are targeting Ca2+ dysregulation, an established hallmark of AD neurons. The NeuroLucent team has uncovered a key intracellular Ca2+ channel that is over-expressed and hyperactive in AD neurons. Preclinical validation has been achieved through the identification of compounds that normalize Ca2+ levels and decrease disease markers in animal models. NeuroLucent is currently focused on identifying a clinical candidate.
Company Details
- Employees
- 2
- Address
- 3333 Green Bay Rd, North Chicago,illinois 60064,united States
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- Website
- neurolucent.com
- HQ
- North Chicago, Illinois
- Competitors
- Crinetics Pharmaceuticals, Inception Labs, healBED.
Neurolucent Questions
Neurolucent's website is neurolucent.com
Neurolucent's LinkedIn profile is https://www.linkedin.com/company/neurolucent
Neurolucent has
2 employees.
View email and phone details for 2
employees at Neurolucent.
Neurolucent's industry is
Mental Health Care
Neurolucent's categories are Mental Health Care
